Drug major Sun Pharma, an Indian multinational pharmaceutical company headquartered in Mumbai, on July 13 announced a slew of changes & reshuffles in the senior management level in its Indian and North American operations.
According to the latest announcement, Abhay Gandhi is the CEO of Sun Pharmaâs North American business. Â On the other hand, Kal Sundaram, CEO of North America business & Taro Pharmaceutical Industries Ltd (Taro), will move to India as CEO (India and emerging markets).
- Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma.
- Effective January 2017, Kal Sundaram, currently CEO, North America business & Taro Pharmaceutical Industries Ltd (Taro, will assume the position of CEO, India and emerging markets.